PPARG and diabetes mellitus: PPAR signaling pathway: direct action of peroxisome proliferator-activated receptors (PPAR)-γ often results in improved insulin sensitivity, which also acts as major drug target for thiazolidinedione (TZD) in the treatment of diabetes mellitus.